A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible

NCT07070960 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
35
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xuzhou Medical University